Apoptosis in the endometrium of postmenopausal women receiving tibolone

Gynecologic and Obstetric Investigation

Volumn 56, Issue 3, 2003, Pages 124-127

  Gökaslan, Hüsnü ^a,b   Öktem, Özgür ^a   Durmuşoǧlu, Fatih ^a   Eren, Funda ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Apoptosis; Endometrium; Postmenopausal women; Tibolone

Indexed keywords

ESTROGEN; TIBOLONE;

ADULT; AMENORRHEA; ANAMNESIS; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOMETRIUM BIOPSY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENOPAUSE; NORMAL HUMAN; PRIORITY JOURNAL; SAMPLING; STATISTICAL SIGNIFICANCE; SYSTEMIC DISEASE;

APOPTOSIS; ATROPHY; ENDOMETRIUM; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE;

EID: 0242288516     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073624     Document Type: Article

References (17)

1. Ginsburg J, Prelevic G, Butler D, Okolo S: Clinical experience with tibolone (Livial) over 8 years. Maturitas 1995;21:71-76.
2. Jones RK, Searle RF, Stewart JA, Turner S, Bulmer JN: Apoptosis, bcl-2 expression, and proliferative activity in human endometrial stroma and endometrial granulated lymphocytes. Biol Reprod 1998;58:995-1002.
3. Akcali KC, Khan SA, Moulton BC: Effect of decidualization on the expression of bax and bcl-2 in rat uterine endometrium. Endocrinology 1996;137:3123-3131.
4. Rymer JM: The effects of tibolone. Gynecol Endocrinol 1998;12:213-220.
5. Volker W, Coelingh Bennink HJ, Helmond FA: Effects of tibolone on the endometrium. Climacteric 2001;4:203-208.
6. Blok LJ, De Ruiter PE, Kuhne EC, Hanekamp EE, Grootegoed JA, Smid-Koopman E, Gielen SC, De Gooyer ME, Kloosterboer HJ, Burger CW: Progestogenic effects of tibolone on human endometrial cancer cells. J Clin Endocrinol Metab 2003;88:2327-2334.
7. Wang S, Pudney J, Song J, Mor G, Schwartz PE, Zheng W: Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia - precursor of endometrial cancer. Gynecol Oncol 2003;88:108-117.
8. Gu Y, Jow GM, Moulton BC, Lee C, Sensibar JA, Park-Sarge OK, Chen TJ, Gibori G: Apoptosis in decidual tissue regression and reorganization. Endocrinology 1994;135:1272-1279.
9. Gompel A, Siromachkova M, Lombet A, Kloosterboer HJ, Rostene W: Tibolone actions on normal and breast cancer cells. Eur J Cancer 2000;36(suppl 4):S76-S77.
10. Kandouz M, Siromachkova M, Jacob D, Chrétien Marquet B, Therwath A, Gompel A: Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Int J Cancer 1996;68:120-125.
11. Alkhalaf M, El-Mowafy A, Karam S: Growth inhibition of MCF-7 human breast cancer cells by progesterone is associated with cell differentiation and phosphorylation of Akt protein. Eur J Cancer Prev 2002;11:481-488.
12. Kandouz M, Lombet A, Perrot JY, Jacob D, Carvajal S, Kazem A, Rostene W, Therwath A, Gompel A: Proapoptotic effects of antiestrogens, progestins and androgens in breast cancer cells. J Steroid Biochem Mol Biol 1999;69:463-471.
13. Gompel A, Chaouat M, Jacob D, Perrot JY, Kloosterboer HJ, Rostene W: In vitro studies of tibolone in breast cells. Fertil Steril 2002;78:351-359.
14. de Gooyer ME, Kleyn GT, Smits KC, Ederveen AG, Verheul HA, Kloosterboer HJ: Tibolone: A compound with tissue specific inhibitory effects on sulfatase. Mol Cell Endocrinol 2001;183:55-62.
15. Kloosterboer HJ: Tibolone: A steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76:231-238.
16. Lippert C, Seeger H, Wallwiener D, Mueck AO: Tibolone versus 17beta-estradiol/norethisterone: Effects on the proliferation of human breast cancer cells. Eur J Gynaecol Oncol 2002;23:127-130.
17. Morsi HM, Leers MP, Radespiel-Troger M, Bjorklund V, Kabarity HE, Nap M, Jager W: Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry. Gynecol Oncol 2000;77:11-17.